Premier Value Extra Strength Tablet, Chewable
NDC Package 68016-678-00
Package Information
Premier Value Extra Strength (calcium carbonate , magnesium hydroxide) tablets is ▪chew 2-4 tablets, hourly if needed. This formulation utilizes a tablet, chewable delivery system. Marketed by Chain Drug Consortium, Llc, this product is identified by NDC 68016-678 and is authorized under FDA application M001.
Identification & Billing
- RxCUI: 476549 - calcium carbonate 675 MG (Ca 270 MG) / magnesium hydroxide 135 MG Chewable Tablet
- RxCUI: 476549 - calcium carbonate 675 MG / magnesium hydroxide 135 MG Chewable Tablet
- RxCUI: 476549 - calcium carbonate 675 MG / milk of magnesia 135 MG Chewable Tablet
Clinical Specifications
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cations, Divalent - [CS]
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 68016 - Chain Drug Consortium, Llc
- 68016-678 - Premier Value Extra Strength
- 68016-678-00 - 100 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
- 68016-678 - Premier Value Extra Strength
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68016-678-00 identifies a specific commercial package of 100 tablet, chewable in 1 bottle, plastic of Premier Value Extra Strength Freshmint Flavor, a human over the counter drug labeled by Chain Drug Consortium, Llc. This tablet, chewable is formulated for oral use and contains calcium carbonate; magnesium hydroxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chain Drug Consortium, Llc on April 18, 2019. The current certification is valid through December 31, 2026.
How is this Chain Drug Consortium, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68016067800. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.